Prevalence of common chronic respiratory diseases in drug misusers: A cohort study

Primary Care Respiratory Journal

Volumn 21, Issue 4, 2012, Pages 377-383

  Palmer, Frances ^a   Jaffray, Mariesha ^a   Moffat, Mandy A ^a   Matheson, Catriona ^a   McLernon, David J ^a   Coutts, Alasdair ^a   Haughney, John ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Adherence; Cohort study; Compliance; Drug users; Respiratory disease; Substance misuse

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CANNABIS; COCAINE; CORTICOSTEROID; GLUE; HYPNOTIC AGENT; OPIATE; PSYCHEDELIC AGENT; PSYCHOSTIMULANT AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG MISUSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; SEX DIFFERENCE; SMOKING;

ADRENAL CORTEX HORMONES; ADULT; ASTHMA; CHRONIC DISEASE; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT DISEASES; SUBSTANCE-RELATED DISORDERS;

EID: 84870923089     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2012.00069     Document Type: Article

References (25)

1. National Institute for Health and Clinical Excellence (NICE). Drug Misuse; Opioid Detoxification. Guideline number 52. London: NICE, 2008.
2. Department of Health. United Kingdom Drug Situation. 2010 Edition. UK Focus point on drugs. Annual report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 29 October 2010.
3. Donnelley RR. The Road to Recovery: A New Approach to Tackling Scotland's Drug Problem. 29 May 2008 (updated 25 March 2011). Available from: http://www.scotland.gov.uk/Publications/2008/05/22161610/0.
4. NHS. National Services Scotland. ISD Scotland Publications. Drug Misuse Statistics Scotland. 2010 (updated 20 April 2011). Available from: www.drugmisuse.isdscotland.org.
5. Matheson C, Jaffray M, Bond CM, et al. A cluster randomised control trial of Enhanced Pharmacy Services (EPS) for methadone patients. CSO Final Report Reference CZH/4/421, 2010.
6. Palmer F. An exploratory study to determine the prevalence of common chronic respiratory diseases in drug misusers. Unpublished Biomedical Science BSC (Hons) Thesis, 2010.
7. Rome LA, Lippmann ML, Dalsey WC, Taggart P, Pomerantz S. Prevalence of cocaine use and its impact on asthma exacerbation in an urban population. Chest 2000;117(5):1324-9. http://dx.doi.org/10.1378/chest.117.5.1324
8. Levine M, Iliescu ME, Margellos-Anast H, Estarziau M, Ansell DA. The effects of cocaine and heroin use on intubation rates and hospital utilization in patients with acute asthma exacerbations. Chest 2005;128(4):1951-7. http://dx.doi.org/10.1378/chest.128.4.1951
9. Osborn HH, Tang M, Bradley K, Duncan BR. New-onset bronchospasm or recrudescence of asthma associated with cocaine abuse. Acad Emerg Med 1997;4(7):689-92. http://dx.doi.org/10.1111/j.1553-2712.1997.tb03761.x
10. Krantz AJ, Hershow RC, Prachand N, Hayden DM, Franklin C, Hryhorczuk DO. Heroin insufflation as a trigger for patients with life-threatening asthma. Chest 2003;123(2):510-17. http://dx.doi.org/10.1378/chest.123.2.510
11. Baxter JD, Samnaliev M, Clark RE. The quality of asthma care among adults with substance-related disorders and adults with mental illness. Psychiatric Services 2009;60(1):43-9. http://dx.doi.org/10.1176/appi.ps.60.1.43
12. Tatum AM, Greenberger PA, Mileusnic D, Donoghue ER, Lifschultz BD. Clinical, pathologic, and toxicologic findings in asthma deaths in Cook County, Illinois. Allergy Asthma Proc 2001;22(5):285-91.
13. Weitzman JB, Kanarek NF, Smialek JE. Medical examiner asthma death autopsies: a distinct subgroup of asthma deaths with implications for public health preventive strategies. Arch Pathol Lab Med 1998;122(8):691-9.
14. Levenson T, Greenberger PA, Donoghue ER, Lifschultz BD. Asthma deaths confounded by substance abuse. An assessment of fatal asthma. Chest 1996;110(3):604-10. http://dx.doi.org/10.1378/chest.110.3.604
15. Tetrault JM, Crothers K, Moore BA, Mehra R, Concato J, Fiellin DA. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med 2007;167(3):221-8. http://dx.doi.org/10.1001/archinte.167.3.221
16. Aldington S, Williams M, Nowitz M, et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax 2007;62(12):1058-63. http://dx.doi.org/10.1136/thx.2006.077081
17. Tashkin DP. Airway effects of marijuana, cocaine, and other inhaled illicit agents. Curr Opin Pulm Med 2001;7(2):43-61. http://dx.doi.org/10.1097/00063198-200103000-00001
18. Tomashefski Jr JF, Felo JA. The pulmonary pathology of illicit drug and substance abuse. Curr Diagn Pathol 2004;10(5):413-26. http://dx.doi.org/10.1016/j.cdip.2004.04.009
19. The Primary Care Clinical Informatics Unit. SPICE: Scottish Programme for Improvement in Clinical Effectiveness. SPICE Reports. Available from: http://www.spice.scot.nhs.uk/SPICE_reports.html (accessed 3 Oct 2011).
20. National Health Service. Read Codes Classification. 2010. Available from: http://www.connectingforhealth.nhs.uk/systemsandservices/data/readcodes (accessed 3 Oct 2011).
21. ISD Scotland. Attendance by Deprivation Category. 2009 (updated 28 July 2005). Available from: http://www.isdscotland.org/isd/1627.html.
22. National Health Service. Quality and Outcomes Framework. 2009. Available from: http://www.qof.ic.nhs.uk/(accessed 3 Oct 2011).
23. Pletcher MJ, Vittinghoff E, Kalhan R, Richman J, Kertesz S. Association between marijuana exposure and pulmonary function over 20 years. JAMA 2012;307(2):173-81. http://dx.doi.org/10.1001/jama.2011.1961
24. Department of Health (England) and the Devolved Administrations (2007). Drug Misuse and Dependence: UK Guidelines on Clinical Management. London: Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive, September 2007.
25. Hunt, N, Griffiths P, Southwell M, Stillwell G, Strang J. Preventing and curtailing injecting drug use: opportunities for developing and delivering 'route transition interventions'. Drug Alcohol Rev 1999;8(4):441-51.